These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3111945)

  • 1. Experimental carotenoid retinopathy. I. Functional and morphological alterations of the rabbit retina after 11 months dietary carotenoid application.
    Weber U; Kern W; Novotny GE; Goerz G; Hanappel S
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):198-205. PubMed ID: 3111945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental carotenoid retinopathy. II. Functional and morphological alterations of the rabbit retina after acute canthaxanthin application with small unilamellar phospholipid liposomes.
    Weber U; Michaelis L; Kern W; Goerz G
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(5):346-50. PubMed ID: 3117623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carotenoid retinopathy. I. Morphologic and functional findings].
    Weber U; Goerz G; Hennekes R
    Klin Monbl Augenheilkd; 1985 May; 186(5):351-4. PubMed ID: 4021422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin.
    Goralczyk R; Buser S; Bausch J; Bee W; Zühlke U; Barker FM
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):741-52. PubMed ID: 9071228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carotinoid retinopathy. II. Electrophysiologic findings in 23 carotenoid-treated patients].
    Weber U; Hennekes R; Goerz G
    Klin Monbl Augenheilkd; 1985 Dec; 187(6):507-11. PubMed ID: 4094362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility of canthaxanthin deposits within the retina.
    Leyon H; Ros AM; Nyberg S; Algvere P
    Acta Ophthalmol (Copenh); 1990 Oct; 68(5):607-11. PubMed ID: 2125796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Canthaxanthin retinopathy and macular pucker].
    Bopp S; el-Hifnawi EL; Laqua H
    J Fr Ophtalmol; 1989; 12(12):891-6. PubMed ID: 2517961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canthaxanthin retinopathy. An investigation by light and electron microscopy and physicochemical analysis.
    Daicker B; Schiedt K; Adnet JJ; Bermond P
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):189-97. PubMed ID: 3111944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canthaxanthin retinopathy. Anatomic and functional reversibility.
    Harnois C; Samson J; Malenfant M; Rousseau A
    Arch Ophthalmol; 1989 Apr; 107(4):538-40. PubMed ID: 2495787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carotinoid retinopathy. III. Reversibility].
    Weber U; Goerz G
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):20-2. PubMed ID: 3959472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Static perimetry in canthaxanthin maculopathy.
    Harnois C; Cortin P; Samson J; Boudreault G; Malenfant M; Rousseau A
    Arch Ophthalmol; 1988 Jan; 106(1):58-60. PubMed ID: 3122712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canthaxanthine-induced retinal pigment epithelial changes in the cat.
    Scallon LJ; Burke JM; Mieler WF; Kies JC; Aaberg TM
    Curr Eye Res; 1988 Jul; 7(7):687-93. PubMed ID: 3138067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinopathy due to canthazanthine: 2. Predisposing factors].
    Cortin P; Boudreault G; Rousseau AP; Tardif Y; Malenfant M
    Can J Ophthalmol; 1984 Aug; 19(5):215-9. PubMed ID: 6434169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Canthaxanthin retinopathy. Follow-up of over 6 years].
    Weber U; Goerz G; Baseler H; Michaelis L
    Klin Monbl Augenheilkd; 1992 Sep; 201(3):174-7. PubMed ID: 1405396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Canthaxanthin retinopathy without intake of canthaxanthin].
    Oosterhuis JA; Remky H; Nijman NM; Craandijk A; de Wolff FA
    Klin Monbl Augenheilkd; 1989 Feb; 194(2):110-6. PubMed ID: 2497265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canthaxanthin retinopathy.
    Lonn LI
    Arch Ophthalmol; 1987 Nov; 105(11):1590-1. PubMed ID: 3118860
    [No Abstract]   [Full Text] [Related]  

  • 17. [Canthaxanthin retinopathy].
    Nijman NM; Oosterhuis JA; van Bijsterveld OP; Baart de la Faille H; Suurmond D
    Klin Monbl Augenheilkd; 1989 Jan; 194(1):48-51. PubMed ID: 2496261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Canthaxanthine retinopathy: 1. Clinical study in 51 consumers].
    Boudreault G; Cortin P; Corriveau LA; Rousseau AP; Tardif Y; Malenfant M
    Can J Ophthalmol; 1983 Dec; 18(7):325-8. PubMed ID: 6423246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of patients taking canthaxanthin and carotene: an electroretinographic and ophthalmological survey.
    Arden GB; Oluwole JO; Polkinghorne P; Bird AC; Barker FM; Norris PG; Hawk JL
    Hum Toxicol; 1989 Nov; 8(6):439-50. PubMed ID: 2512247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [En pailettes d'or maculopathy caused by carotinoid therapy].
    Hübner U; Frühauf A; Barth J
    Dermatol Monatsschr; 1986; 172(3):177-8. PubMed ID: 3084313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.